TPM2 Gene Arthrogryposis distal type 1A Genetic Test
At DNA Labs UAE, we offer the TPM2 Gene Arthrogryposis distal type 1A Genetic Test. This genetic test is designed to identify mutations or variations in the TPM2 gene that are associated with a condition called arthrogryposis, distal, type 1A.
Test Components
The test includes the following components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the TPM2 Gene Arthrogryposis distal type 1A Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with TPM2 Gene Arthrogryposis, distal, type 1A NGS Genetic DNA Test gene TPM2.
Test Details
The TPM2 gene arthrogryposis, distal, type 1A NGS genetic test is a genetic test that aims to identify mutations or variations in the TPM2 gene. This gene is responsible for producing a protein called beta-tropomyosin, which plays a role in muscle contraction and movement.
Arthrogryposis is a condition characterized by multiple joint contractures, leading to restricted movement. In the case of distal arthrogryposis, the joints of the hands and feet are primarily affected, resulting in abnormalities such as clenched fists, overlapping fingers, and clubfoot.
Next-Generation Sequencing (NGS) technology is utilized in this genetic test. NGS is a high-throughput DNA sequencing technology that allows for the rapid sequencing of large amounts of genetic material. It enables the analysis of the entire coding region of the TPM2 gene, along with other relevant genes, to identify any mutations or variations present.
By identifying mutations in the TPM2 gene, the NGS genetic test can provide a definitive diagnosis of arthrogryposis, distal, type 1A. This information is crucial in guiding treatment and management strategies for individuals with this condition. It also offers valuable insights for family planning and genetic counseling purposes.
At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. Our TPM2 Gene Arthrogryposis distal type 1A Genetic Test can help individuals and their families understand and manage this condition effectively.
Test Name | TPM2 Gene Arthrogryposis distal type 1A Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TPM2 Gene Arthrogryposis, distal, type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TPM2 Gene Arthrogryposis, distal, type 1A NGS Genetic DNA Test gene TPM2 |
Test Details |
TPM2 gene arthrogryposis, distal, type 1A NGS genetic test is a genetic test that looks for mutations or variations in the TPM2 gene that are associated with a condition called arthrogryposis, distal, type 1A. Arthrogryposis is a condition characterized by multiple joint contractures, or stiff joints, that restrict movement. Distal arthrogryposis specifically affects the joints of the hands and feet, causing abnormalities such as clenched fists, overlapping fingers, and clubfoot. The TPM2 gene provides instructions for making a protein called beta-tropomyosin, which is involved in muscle contraction and movement. Mutations in this gene can disrupt the normal function of beta-tropomyosin, leading to the development of arthrogryposis. NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the rapid sequencing of large amounts of genetic material. In the context of genetic testing, NGS can be used to analyze the entire coding region of the TPM2 gene, as well as other relevant genes, to identify any mutations or variations that may be present. By identifying mutations in the TPM2 gene, the NGS genetic test can provide a definitive diagnosis of arthrogryposis, distal, type 1A. This information can be used to guide treatment and management strategies for individuals with this condition. Additionally, it can also provide valuable information for family planning and genetic counseling purposes. |